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The hepatitis C virus (HCV) is the most common
blood-borne infection and affects approximately 2% of
the U.S. population, with higher rates occurring in some
segments of the population. Chronic pain affects
approximately 35% of the general population, with 15%
of individuals experiencing daily pain. In contrast, the
prevalence of chronic pain among HCV patients may
exceed 65%.
The reasons for the high rates of chronic pain among
H C Vp a t i e n t sa r en o tc l e a r .M o r et h a nt w o - t h i r d so f
HCV patients have a history of substance use disorder
(SUD), and history of SUD is associated with the devel-
opment of pain. HCV patients also have high rates of
co-morbid psychiatric disorders, which are also asso-
ciated with chronic pain.
The purpose of this presentation will be to outline the
issue of chronic pain and substance use among HCV
patients and to describe factors that may lead to the
high rate of chronic pain in this patient population. The
results of ongoing studies that examined the role of
biopsychosocial factors in the development and exacer-
bation of chronic pain in HCV patients will also be
described.
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